Pacira BioSciences Inc. (PCRX)
NASDAQ: PCRX
· Real-Time Price · USD
24.75
-0.24 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
24.78
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Pacira BioSciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 300.48M | 283.61M | 276.77M | 245.97M | 247.05M | 184.05M | 153.3M | 99.12M | 86.81M | 35.55M | 104.14M | 109.42M | 122.06M | 226.75M | 585.58M | 134.04M | 105.77M | 66.7M |
Short-Term Investments | 145.38M | 210.02M | 207.84M | 207.84M | 157.17M | 141.84M | 125.28M | 136.07M | 133.96M | 138.45M | 184.51M | 219.3M | 194.33M | 225.44M | 70.83M | 559.82M | 540.82M | 523.36M |
Long-Term Investments | 18.81M | n/a | n/a | 36.73M | 36.5M | 36.54M | 2.41M | 35.55M | 35.63M | 40.57M | 64.38M | 43.75M | 35.81M | 35.77M | 21.99M | 21.19M | 17.97M | 51.02M |
Other Long-Term Assets | n/a | 28.03M | 35.65M | n/a | n/a | n/a | 36.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 114.37M | 104.75M | 113.3M | 100.65M | 104.78M | 101.64M | 105.56M | 96.96M | 99.08M | 93.2M | 98.4M | 93.47M | 91.11M | 92.1M | 96.32M | 49.98M | 68.36M | 52.58M |
Inventory | 148.16M | 133.75M | 125.28M | 111.86M | 103.44M | 96.78M | 104.35M | 96.52M | 92.13M | 92.98M | 96.06M | 96.8M | 100.59M | 103.66M | 98.55M | 67.21M | 65.26M | 64.61M |
Other Current Assets | 37.22M | 27.84M | 21.93M | 23.64M | 19.77M | 18.8M | 21.5M | 18.59M | 17.35M | 15.93M | 15.22M | n/a | n/a | n/a | 14.77M | n/a | 12.36M | 12.99M |
Total Current Assets | 745.61M | 759.96M | 745.13M | 689.97M | 632.21M | 543.11M | 509.99M | 447.25M | 429.32M | 376.11M | 498.33M | 533.41M | 526.21M | 667.02M | 866.05M | 822.35M | 792.58M | 720.25M |
Property-Plant & Equipment | 201.71M | 213.18M | 216.39M | 220.68M | 225.11M | 230.43M | 234.95M | 239.18M | 246.15M | 249.7M | 254.39M | 263.31M | 263.36M | 264.04M | 264.81M | 229.03M | 224.55M | 217.71M |
Goodwill & Intangibles | 442.86M | 456.49M | 425.97M | 440.29M | 617.86M | 632.18M | 646.5M | 660.82M | 675.14M | 689.47M | 703.79M | 738.36M | 741.46M | 755.37M | 769.14M | 190.17M | 192.13M | 194.1M |
Total Long-Term Assets | 791.65M | 826.71M | 808.39M | 831.72M | 1.01B | 1.04B | 1.06B | 1.09B | 1.11B | 1.15B | 1.18B | 1.2B | 1.21B | 1.22B | 1.21B | 533.65M | 533.25M | 567.3M |
Total Assets | 1.54B | 1.59B | 1.55B | 1.52B | 1.65B | 1.58B | 1.57B | 1.53B | 1.54B | 1.52B | 1.68B | 1.73B | 1.73B | 1.89B | 2.08B | 1.36B | 1.33B | 1.29B |
Account Payables | 30.12M | 23.17M | 19.13M | 19.37M | 18.73M | 8.98M | 15.7M | 16.51M | 24.21M | 17.26M | 15.22M | 12.93M | 13.98M | 14.84M | 10.54M | 7.89M | 12.18M | 9.11M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.64M | -8.64M | n/a | n/a | n/a | n/a | 10.13M | 10.13M | 51.19M | 52.16M | 50.96M |
Short-Term Debt | 202.4M | 202.09M | 201.78M | 201.47M | 9.15M | 8.64M | 8.64M | 8.64M | 19.5M | 19.8M | 42.77M | 42.24M | 41.91M | 193.68M | 374.7M | 155.75M | 153.68M | 151.65M |
Other Current Liabilities | n/a | n/a | 28.81M | n/a | n/a | n/a | 8.53M | n/a | n/a | -8.95M | 54.47M | -8.36M | -8.13M | n/a | 9.38M | 5.46M | 5.03M | 15.59M |
Total Current Liabilities | 313.16M | 314.73M | 309.92M | 306.4M | 92.69M | 93.44M | 97.38M | 93.66M | 108.91M | 98.7M | 147.77M | 131.53M | 133.18M | 305.07M | 521.12M | 225.79M | 228.69M | 232.08M |
Long-Term Debt | 378.1M | 381.29M | 383.55M | 385.89M | 589.3M | 511.69M | 513.8M | 515.94M | 532.18M | 542.92M | 655.82M | 714M | 721.88M | 729.74M | 674.53M | 326.15M | 321.71M | 317.34M |
Other Long-Term Liabilities | 42.36M | 41.43M | 37.06M | 31.94M | 35.41M | 33.58M | 38.27M | 36.22M | 33.27M | 51.32M | 37.79M | 53.32M | 54.72M | 67.25M | 67.44M | 18.68M | 20.03M | 17.64M |
Total Long-Term Liabilities | 466.33M | 473.4M | 465.25M | 465.71M | 674.85M | 597.72M | 606.87M | 609.25M | 625.49M | 656.68M | 758.42M | 832.72M | 844.17M | 876.83M | 823.83M | 411.61M | 409.97M | 404.65M |
Total Liabilities | 779.5M | 788.13M | 775.17M | 772.11M | 767.54M | 691.16M | 704.26M | 702.91M | 734.41M | 755.38M | 906.19M | 964.24M | 977.35M | 1.18B | 1.34B | 637.4M | 638.66M | 636.73M |
Total Debt | 631.4M | 636.46M | 638.85M | 644.42M | 648.6M | 581.78M | 586.04M | 590.3M | 620.71M | 625.16M | 763.39M | 821.64M | 831.36M | 1B | 1.13B | 554.56M | 549.27M | 544.15M |
Common Stock | 48K | 47K | 47K | 47K | 47K | 47K | 46K | 46K | 46K | 46K | 46K | 46K | 46K | 45K | 45K | 45K | 44K | 44K |
Retained Earnings | -206.39M | -201.54M | -206.36M | -222.4M | -78.93M | -97.82M | -106.8M | -131.67M | -142.52M | -168.29M | -148.75M | -138.65M | -137.96M | -157.83M | -211.9M | -206.76M | -224.43M | -243.51M |
Comprehensive Income | 4.06M | 1.35M | 343K | 678K | 105K | 152K | 247K | -10K | -173K | -137K | -380K | -670K | -605K | -527K | 167K | 153K | 181K | 172K |
Shareholders Equity | 757.77M | 798.54M | 778.35M | 749.58M | 879.28M | 892.16M | 870.13M | 831.55M | 807.98M | 768.04M | 775.01M | 770.12M | 756.64M | 709.58M | 730.41M | 718.6M | 687.17M | 650.82M |
Total Investments | 164.19M | 210.02M | 207.84M | 244.57M | 193.67M | 178.38M | 127.69M | 171.62M | 169.58M | 146.74M | 248.89M | 263.05M | 230.14M | 261.21M | 92.82M | 581.01M | 558.79M | 574.39M |